Ipca Laboratories Ltd.

IPCALAB Share PricePharmaceuticals & Drugs

1,459.1

4.5 (0.3%)

As on December 5, 2025

Exchange Scrips: BSE524494NSEIPCALABISININE571A01038

Market Cap37,018 Cr

P/E Ratio 50.18

Dividend Yield 0.27 %

Performance

Market performance

Open1,449.9
High1,463.5
Volumes2,37,723
Prev1,459.1
Low1,416
As on2025-12-05

Historical performance

1 Year High1,755.9
3 Year High1,755.9
5 Year High1,755.9
1 Year Low1,168.2
3 Year Low669.8
5 Year Low669.8

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
37,018
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
50.18
Dividend Yield
Dividend Yield
0.27 %

Investment Returns

1 Year
-2.3%
3 Years
68.9%
5 Years
29.6%
10 Years
277.6%

Technicals

IndicatorsValueSignal
5-DMA1,441.48Bullish
10-DMA1,429.98Bullish
20-DMA1,415.32Bullish
50-DMA1,352.86Bullish
100-DMA1,377.25Bullish
200-DMA1,388.69Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters1416161616
Foreign Investors---------------
Domestic Investors1416161616
Public Investors8285685566882909017382959
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 50.18.
  • 3Y Stock Price CAGR of the stock is 19.7.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹18218 Million.
  • The company generated revenue of ₹88968 Million in the previous financial year.

Ipca Laboratories Ltd.

1459.14.5   (0.3%)

Investment Amount: ₹ 1000000
Current Value: ₹ 957571.8
No. of Shares: 656 (Approx)
Performance:-4.2%
P/L: ₹-42428.2

Top Gainers

SymbolChange%
ARVEE197.48(20%)
KESORAMIND6.54(20%)
KEYFINSERV338.85(19%)
ROLLT1.37(19%)
FILATFASH0.42(14%)

Top Losers

SymbolChange%
KAYNES4353.5(-13%)
STEL547.4(-11%)
RAJSREESUG31.45(-9%)
HCC19.9(-9%)
LAGNAM67.29(-8%)
TOTAL79.43(-8%)
EASEMYTRIP7.7(-8%)
AVG163.24(-7%)

Peer Comparison

Venus Remedies Ltd.

68.1%

745.05

1 Month Performance

Nectar Lifesciences Ltd.

49.5%

20.95

1 Month Performance

Ortin Global Ltd.

36.7%

15.61

1 Month Performance

Natco Pharma Ltd.

13.9%

933.6

1 Month Performance

Haleos Labs Ltd.

13%

1335

1 Month Performance

SMS Pharmaceuticals Ltd.

12.9%

317

1 Month Performance

Bliss GVS Pharma Ltd.

11.4%

171.23

1 Month Performance

Orchid Pharma Ltd.

9.8%

867.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month